Jaguar Health (JAGX) Free Cash Flow (2014 - 2026)
Jaguar Health (JAGX) reported Free Cash Flow of $8.8 million for Q1 2026, up 220.73% year-over-year from $2.8 million in Q1 2025, and up 261.28% quarter-over-quarter from -$5.5 million in Q4 2025.
Jaguar Health (JAGX) Free Cash Flow (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Free Cash Flow data on file, last reported at $8.8 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at $8.8 million, up 220.73% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.5 million (up 74.61% YoY), and the FY2025 annual result was -$23.7 million, up 19.3% from the prior year.
- Free Cash Flow climbed to $8.8 million in Q1 2026 per JAGX's latest filing, from -$5.5 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $8.8 million in Q1 2026 and troughed at -$10.5 million in Q2 2022.
- A 5-year average of -$6.5 million and a median of -$7.3 million in 2025 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2023 and 2026: Free Cash Flow declined 29.24% in 2023, then surged 220.73% in 2026.
- A 5-year view of Free Cash Flow shows it stood at -$6.4 million in 2022, then dropped by 16.0% to -$7.5 million in 2023, then decreased by 5.03% to -$7.8 million in 2024, then jumped by 30.04% to -$5.5 million in 2025, then jumped by 261.28% to $8.8 million in 2026.
- Business Quant data shows JAGX's Free Cash Flow at $8.8 million in Q1 2026, -$5.5 million in Q4 2025, and -$4.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 63,220.27 |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 8.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.83 Mn |
| Mar 31, 2026 | 8.83 Mn |
| Dec 31, 2025 | -5.48 Mn |
| Dec 31, 2025 | -5.48 Mn |
| Sep 30, 2025 | -4.69 Mn |
| Sep 30, 2025 | -4.69 Mn |
| Jun 30, 2025 | -6.20 Mn |
| Jun 30, 2025 | -6.20 Mn |
| Mar 31, 2025 | -7.31 Mn |
| Mar 31, 2025 | -7.31 Mn |
| Dec 31, 2024 | -7.83 Mn |
| Dec 31, 2024 | -7.83 Mn |
| Sep 30, 2024 | -6.34 Mn |
| Sep 30, 2024 | -6.34 Mn |
| Jun 30, 2024 | -8.17 Mn |
| Jun 30, 2024 | -8.17 Mn |
| Mar 31, 2024 | -7.05 Mn |
| Mar 31, 2024 | -7.05 Mn |
| Dec 31, 2023 | -7.45 Mn |
| Dec 31, 2023 | -7.45 Mn |